Pages that link to "Q24540058"
The following pages link to Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma (Q24540058):
Displaying 50 items.
- Liver Transplantation for Hepatocellular Carcinoma: Need for a New Patient Selection Strategy: Reply (Q24540174) (← links)
- Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA (Q24672943) (← links)
- Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review (Q26772299) (← links)
- Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation (Q26772329) (← links)
- Management of "very early" hepatocellular carcinoma on cirrhotic patients (Q26864406) (← links)
- Management of hepatocellular carcinoma with portal vein thrombosis (Q26996578) (← links)
- Diagnostic and therapeutic management of hepatocellular carcinoma (Q26999043) (← links)
- New insights in hepatocellular carcinoma: from bench to bedside (Q27026454) (← links)
- Liver transplantation for advanced hepatocellular carcinoma (Q28074653) (← links)
- Hepatocellular carcinoma: A comprehensive review (Q28087638) (← links)
- Management of HCC (Q28258769) (← links)
- Management of hepatocellular carcinoma (Q29616230) (← links)
- Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort (Q30416480) (← links)
- Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation (Q30430659) (← links)
- Laparoscopic liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: midterm results and perspectives (Q33237223) (← links)
- Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation (Q33647365) (← links)
- SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis. (Q33683019) (← links)
- Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients (Q33866483) (← links)
- Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies (Q34017735) (← links)
- Retracted: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation (Q34038193) (← links)
- Long-term results of liver transplantation for hepatocellular carcinoma: an update of the University of Padova experience (Q34662021) (← links)
- Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis. (Q34776673) (← links)
- Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis (Q35058719) (← links)
- Positron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignancies (Q35397108) (← links)
- Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants (Q35751531) (← links)
- Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma (Q35867075) (← links)
- Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again (Q36082480) (← links)
- CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model (Q36148211) (← links)
- Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma (Q36179125) (← links)
- Liver transplantation(). (Q36340199) (← links)
- Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma (Q36474467) (← links)
- Strategies for the management of hepatocellular carcinoma (Q36863488) (← links)
- Pre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation? (Q36875442) (← links)
- Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome (Q36962089) (← links)
- Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers (Q37107619) (← links)
- Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies (Q37140667) (← links)
- Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation. (Q37162432) (← links)
- Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis (Q37636484) (← links)
- Current controversies surrounding liver transplantation for hepatocellular carcinoma (Q37769279) (← links)
- Critical review of controversial issues in the management of advanced pediatric liver tumors (Q37864612) (← links)
- Criteria for liver transplantation for HCC: What should the limits be? (Q37896238) (← links)
- Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: A review and consensus statement (Q37900264) (← links)
- Current opinion on the role of resection and liver transplantation for hepatocellular cancer (Q38019845) (← links)
- Liver transplantation and expanded Milan criteria: does it really work? (Q38046482) (← links)
- Liver Transplantation for HCC: A Review (Q38078347) (← links)
- Resection and transplantation for hepatocellular carcinoma: factors influencing surgical options (Q38206274) (← links)
- Living donor liver transplantation for patients with hepatocellular carcinoma (Q38221511) (← links)
- Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation (Q38269467) (← links)
- Super-selection of a subgroup of hepatocellular carcinoma patients at minimal risk of recurrence for liver transplantation (Q38474433) (← links)
- Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals (Q38763789) (← links)